.
Angewandte
Communications
H.-M. Park, K. H. Yoo, T. Sim, J. S. Tae, S. H. Lee, Bioorg. Med.
[7] For some recent reviews: a) H. Kumar, D. Saini, S. Jain, N. Jain,
S¸enkardes¸, Eur. J. Med. Chem. 2015, 97, 786.
b) L. Bellarosa, J. Diez, J. Gimeno, A. Lledos, F. J. Suarez, G.
formation of the pyrazoles 13. Importantly, determination of
the enantiomeric purity on the products derived from the
enantiomerically pure tosylhydrazone revealed an enantio-
meric ratio of greater than 99:1, thus indicating that the whole
process had proceeded again with complete preservation of
the chiral information.
In summary, we have presented herein a straightforward
synthesis of unprecedented chiral pyrazoles from terminal
alkynes and a-chiral-N-tosylhydrazones, through a cascade
process which involves a 1,3-dipolar cycloaddition followed
by a [1,5] sigmatropic rearrangement. It is important to note
that the appropriate selection of substituents in the starting
tosylhydrazones leads to reactions that are highly selective on
three different levels: 1) chemoselectivity: one of the two
possible groups undergoes migration; 2) regioselectivity: the
migration takes place preferentially to one of the two possible
positions; 3) stereospecificity: the migration of stereogenic
groups occurs with retention of configuration. From a mech-
anistic point of view, to the best of our knowledge, we have
provided here the first [1,5] sigmatropic rearrangements with
retention of configuration within the migrating group which
does not involve spirocyclic systems. The reaction also
employs enantiomerically pure materials. Therefore, these
are unique examples of a largely anticipated stereospecific
transformation. Finally, and taking into account the ready
availability of the starting materials required for these
reactions, these results open the possibility of developing
applications of these new classes of pyrazoles in medicinal
chemistry and as chiral ligands for transition metals.
[9] J. PØrez, L. Riera, Eur. J. Inorg. Chem. 2009, 4913.
[10] For some examples, see: a) E. Cavero, S. Uriel, P. Romero, J. L.
Beltrµn, E. Cavero, J. Barberµ, J. L. Serrano, A. Elduque, R.
[11] For a recent review, see: S. Fustero, M. Sµnchez-Roselló, P.
[12] For some relevant recent examples, see: a) Y. Kong, M. Tang, Y.
d) E. Decuypere, S. Specklin, S. Gabillet, D. Audisio, H. Liu, L.
Yang, S. Ye, D. Fanning, T. Coon, Y. Schmidt, P. Krenitsky, D.
g) S. Mantenuto, F. Mantellini, G. Favi, O. A. Attanasi, Org. Lett.
[13] a) F. Brookfield, J. Burch, R. A. Goldsmith, B. Hu, K. H. L. Lau,
C. H. Mackinnon, D. F. Ortwine, Z. Pei, G. Wu, P.-W. Yuen, Y.
Zhang, WO2014023258, Hoffmann-La Roche AG, Switz.;, 2014;
b) S. Stokes, N. Foloppe, A. Fiumana, M. Drysdale, S. Bedford, P.
Webb, WO2009093012, Vernalis R & D Ltd, 2009.
[15] H. Mastalerz, M. Chang, P. Chen, P. Dextraze, B. E. Fink, A.
Gavai, B. Goyal, W.-C. Han, W. Johnson, D. Langley, F. Y. Lee, P.
Marathe, A. Mathur, S. Oppenheimer, E. Ruediger, J. Tarrant,
J. S. Tokarski, G. D. Vite, D. M. Vyas, H. Wong, T. W. Wong, H.
[16] X. Hu, B. Gao, Y. Chu, W. Li, X. Liu, L. Lin, X. Feng, Chem. Eur.
[17] Q. Lin, D. Meloni, Y. Pan, M. Xia, J. Rodgers, S. Shepard, M. Li,
L. Galya, B. Metcalf, T.-Y. Yue, P. Liu, J. Zhou, Org. Lett. 2009,
11, 1999.
[19] In a very recent publication employing terminal alkynes and
cycloalkyltosylhydrazones, under very similar reaction condi-
tions, 3H-pyrazoles were isolated in some cases: R. R. Merchant,
[20] a) Y.-P. Yen, S.-F. Chen, Z.-C. Heng, J.-C. Huang, L.-C. Kao, C.-
Acknowledgements
We gratefully acknowledge financial support of this work
from Ministerio de Economía y Competitividad of Spain
(Grant: MINECO-CTQ2013-41336-P). A FPI predoctoral
fellowship to M.C.P.-A. is gratefully acknowledged.
Keywords: cycloaddition · diazo compounds · heterocycles ·
rearrangements · tosylhydrazone
How to cite: Angew. Chem. Int. Ed. 2015, 54, 13729–13733
Angew. Chem. 2015, 127, 13933–13937
[1] J. Elguero, A. M. S. Silva, A. C. TomØ, in Modern Heterocyclic
Chemistry, Vol. 2 (Eds. J. Alvarez-Builla, J. J. Vaquero, J. Bar-
luenga), Wiley-VCH, Weinheim, 2011, pp. 635 – 725.
[2] A. Schmidt, A. Dreger, Curr. Org. Chem. 2011, 15, 1423.
[4] R. Riedel, Arzneim.-Forsch. 1981, 31, 655.
[21] See the Supporting Information for details on computational
studies.
[5] M. L. Isidro, F. Cordido, Mini-Rev. Med. Chem. 2009, 9, 664.
[6] For a selection some recent examples: a) R. B. Pathak, P. T.
5129; b) T. B. Abu, M. Arnsmann, F. Totzke, J. E. Ehlert,
M. H. G. Kubbutat, C. Schachtele, M. O. Zimmermann, P.
Koch, F. M. Boeckler, S. A. Laufer, J. Med. Chem. 2012, 55,
961; c) S. R. Donohue, R. F. Dannals, C. Halldin, V. W. Pike, J.
Park, M. M. Al-Sanea, A. Z. Abdelazem, H. M. Park, E. J. Roh,
[22] For the [1,5] sigmatropic rearrangements on 3H-pyrazole-5-
carboxylates and 3H-pyrazoles-4,5-dicarboxylates, depending on
the nature of the migrating substituent, mechanisms that range
from concerted [1,5] sigmatropic rearrangements to ionic step-
wise processes involving the presence of ion pairs have been
ꢀ 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Angew. Chem. Int. Ed. 2015, 54, 13729 –13733